Disclosure: STOCK Act Trades may earn a commission from products and services recommended on this site. This does not affect our editorial independence or the accuracy of our data.

Congressional Trading Alpha: A Forensic Analysis of Legislative Portfolio Allocations, Market Catalysts, and Regulatory Intersections (Nov/Dec 2025)

1. Executive Summary

The intersection of federal legislative privilege and capital market allocation serves as one of the most potent, albeit opaque, leading indicators in the global financial ecosystem. By aggregating, sanitizing, and rigorously analyzing the disparate data points of congressional stock transactions filed between November and December 2025, a distinct pattern of "information arbitrage" and sector-specific rotation emerges. This report synthesizes a granular review of transaction disclosures from high-ranking members of the United States Congress—specifically Members of the House Financial Services Committee, Senate Agriculture Committee, and Senate Banking Committee—with a forensic examination of concurrent macroeconomic developments, sector-specific regulatory shifts, and corporate catalysts.

The analysis indicates that congressional trading activity during this period was not stochastic. Rather, it was highly concentrated in sectors undergoing profound structural shifts driven by federal policy: the physical constraints of Artificial Intelligence (AI) infrastructure, the legislative legitimization of digital assets, the reimbursement reform of precision medicine, and the interest-rate sensitivity of the housing market.

Core Thematic Findings

The data reveals a concerted accumulation of assets tied to the "second derivative" of the AI revolution—specifically power generation and data center capacity—by members sitting on committees with direct oversight of energy and technology standards. Furthermore, a distinct cluster of transactions in the biotechnology sector preceded material regulatory approvals by the Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS), suggesting a strong correlation between legislative oversight roles and positive regulatory outcomes.

Perhaps most notably, the analysis identifies a "macro-pivot" by key Senate leadership, specifically within the Agriculture Committee, moving away from broad equity exposure and inflation hedges toward Mortgage-Backed Securities (MBS). This rotation signals a high-conviction legislative belief in the stabilization of interest rates and a targeted effort to support rural housing liquidity.

The "Sleeper" Anomalies

This report identifies specific "sleeper" anomalies—assets that exhibited unusual congressional accumulation patterns prior to broader market recognition of their fundamental catalysts. By triangulating committee assignments with specific ticker symbols, this research isolates potential high-value opportunities that align with the non-public or specialized knowledge likely accessible to these policymakers.

The following comprehensive analysis treats congressional trades not merely as personal financial decisions, but as signals of legislative intent and regulatory probability. The objective is to reverse-engineer the investment theses of key policymakers to uncover undervalued assets poised for re-rating in early 2026.

---

2. The AI Infrastructure Divergence: Energy, Compute, and the "Pick-and-Shovel" Pivot

The most significant thematic cluster identified in the December 2025 congressional transaction logs centers on the infrastructure underpinning Artificial Intelligence. While the broader retail market remained fixated on semiconductor designers and software applications, astute congressional trading activity shifted noticeably toward the physical constraints of the AI boom: energy generation, data center hosting, and specialized cloud infrastructure. This shift aligns with growing legislative awareness of the power constraints facing the U.S. electrical grid and the strategic imperative of domestic compute capacity.

2.1 IREN Limited (IREN): The Energy Bottleneck Play

A standout transaction during this period was the purchase of IREN Limited (NASDAQ: IREN) by Representative Cleo Fields (D-LA) on December 9, 2025.1 Representative Fields, a member of the House Financial Services Committee with jurisdiction over digital assets, financial technology, and AI innovation 2, executed this trade at a critical inflection point for the company.

IREN, formerly known as Iris Energy, represents a hybrid asset class that sits at the nexus of cryptocurrency mining and high-performance computing (HPC) for AI. The analysis of IREN’s corporate developments in late 2025 reveals a company aggressively pivoting away from pure-play Bitcoin mining toward AI cloud services—a transition that appears to have garnered specific legislative attention due to its implications for energy policy.

The Microsoft Catalyst and Revenue Projections

The fundamental backdrop for this trade involves a transformative agreement between IREN and Microsoft. In November 2025, IREN secured a $9.7 billion AI cloud contract with Microsoft, a deal structured to generate approximately $1.9 billion in annual recurring revenue (ARR).4 This contract validates IREN’s strategy of utilizing its renewable energy-powered data centers for energy-intensive AI workloads, effectively decoupling its long-term value proposition from the volatility of Bitcoin prices.

Market analysis suggests that IREN is targeting $3.4 billion in annualized AI cloud revenue by the end of 2026.4 This projection implies a staggering growth trajectory compared to its fiscal 2025 revenue of roughly $501 million, which was predominantly derived from crypto mining.4 The accumulation of IREN stock by a member of the Financial Services Committee—which has been holding hearings on "Enabling 21st Century AI Innovation in Financial Services" 7—suggests a high degree of confidence in the company’s ability to execute this pivot despite broader market skepticism regarding AI capital expenditures.9

Energy Regulation and Grid Interconnection

The strategic value of IREN lies in its secured power portfolio. As AI models grow in complexity, the demand for electricity has outpaced grid capacity, creating a bottleneck that few companies can circumvent. IREN currently operates with 3 gigawatts of secured power, a resource that has become increasingly scarce and valuable.5

Simultaneously, the Senate Energy and Natural Resources Committee has been actively pressuring the Federal Energy Regulatory Commission (FERC) to expedite rule-making regarding the interconnection of "large loads"—specifically data centers—to the grid.10 Senators Mike Lee and Martin Heinrich have publicly supported Department of Energy proposals to streamline this process, citing the need for American energy dominance and AI advancement.10

Representative Fields' purchase of IREN aligns with this legislative tailwind. By holding an asset that already possesses the necessary power infrastructure and land rights, the investor is insulated from the regulatory delays slowing down greenfield data center projects. Furthermore, IREN's focus on 100% renewable energy mitigates the growing political backlash from environmental groups urging a moratorium on data center construction due to fossil fuel consumption.11

Evaluation as a "Sleeper" Stock

IREN exhibits the classic characteristics of a "sleeper" stock in this context. Despite the massive Microsoft contract, the stock experienced significant volatility in late 2025, dropping more than 50% from its highs due to unrelated rumors regarding Oracle and general sector profit-taking.12 This disconnect between price action and fundamental execution (the secured backlog of $55 billion and rapid deployment of NVIDIA GPUs) created an entry point that Representative Fields appears to have utilized.

The synthesis of IREN’s aggressive expansion plan—scaling to 140,000 GPUs by 2026—and the bipartisan legislative push to secure U.S. AI infrastructure suggests that IREN is undervalued relative to its contracted future cash flows. The transaction serves as a strong signal that the "energy bottleneck" thesis is gaining traction within the halls of Congress.

2.2 CoreWeave (CRWV): The Exit Signal

Conversely, the data shows Representative Fields selling shares of CoreWeave (NASDAQ: CRWV) on December 11, 2025.1 This transaction occurred in the wake of CoreWeave's IPO earlier in the year and amidst significant volatility related to lock-up expirations and capital raising activities.

CoreWeave, essentially a specialized cloud provider renting NVIDIA GPUs to AI developers, has been a darling of the AI boom, securing massive valuations and backing from Nvidia itself.13 However, the company’s aggressive capital expenditure requirements—spending billions to build out data centers—have necessitated heavy borrowing and dilutive equity offerings.14

The Liquidity Event Context

The timing of the sale is notable. Reports indicate that CoreWeave’s IPO lock-up period, typically 180 days, would have expired around September 2025, leading to potential insider selling pressure in Q4 2025.15 Additionally, in December, reports surfaced regarding potential block sales by early investors, which can depress stock prices in the short term.13

Representative Fields’ decision to exit the position in mid-December suggests a desire to lock in gains before further volatility associated with these liquidity events or potential execution risks in 2026. While CoreWeave reported strong Q3 2025 revenue growth of 134% year-over-year 17, the company’s net loss widened due to soaring interest expenses 14, and it faces challenges in maintaining margins as hyperscalers build their own capacity.

Comparative Analysis: IREN vs. CoreWeave

The diverging actions of Representative Fields—buying IREN while selling CoreWeave—offer a nuanced insight into the legislative view of the AI sector. Both companies operate in the same ecosystem (AI compute infrastructure), but their economic models differ.

The shift from CoreWeave to IREN suggests a preference for owning the scarce resource (power/capacity) over the service layer (rental compute), which is becoming increasingly commoditized and capital-intensive. For an investor looking for a sleeper, this pivots the focus toward companies with secured power interconnection queues rather than just high GPU counts.

2.3 SoundHound AI (SOUN): The Software Lag

The data also shows Representative Fields selling SoundHound AI (NASDAQ: SOUN) on December 15, 2025.1 SoundHound, a player in voice AI, represents the software application layer of the industry.

Despite the optimism surrounding AI software in 2026 18, SoundHound has struggled with profitability, posting negative net margins and significant insider selling throughout late 2025.19 Executives, including the CEO and CFO, sold substantial amounts of stock in December to cover tax obligations.19 While routine, such heavy insider selling often acts as a headwind.

The sale reinforces the thesis that the immediate alpha in AI lies in the infrastructure build-out (IREN) rather than the application layer, which is still proving its monetization models. Legislative interest currently favors the "hard assets" required to maintain U.S. technological supremacy (chips and power) over consumer-facing applications.

2.4 Texas Instruments (TXN): The Domestic Manufacturing Play

Representative Thomas H. Kean (R-NJ) purchased Texas Instruments (NASDAQ: TXN) on November 26, 2025.1 This purchase coincides with significant developments regarding the U.S. CHIPS and Science Act and the onshoring of semiconductor manufacturing.

In late 2025, Texas Instruments officially began production at its new 300mm semiconductor fabrication plant in Sherman, Texas.21 This $40 billion investment is a direct beneficiary of federal incentives aimed at reducing reliance on Asian supply chains. The facility creates a long-term domestic supply of analog chips, which are critical for automotive and industrial applications—sectors heavily emphasized in recent bipartisan infrastructure legislation.

Kean’s purchase suggests confidence in the cyclical recovery of the semiconductor industry, specifically the analog sub-sector, which had faced inventory corrections earlier in the year.22 By investing in TXN as it brings new domestic capacity online, the trade aligns with the broader "industrial policy" narrative dominating Washington.

---

3. The Crypto Regulatory Arbitrage: Bitcoin ETFs and the Senate Banking Committee

The transaction logs for Senator Dave McCormick (R-PA) reveal a highly concentrated and aggressive accumulation of the Bitwise Bitcoin ETF (BITB) in late November 2025. Between November 24 and November 28, Senator McCormick executed multiple purchases ranging from $50,000 to $100,000, totaling substantial exposure to Bitcoin.1

This trading activity is particularly significant given Senator McCormick’s committee assignments. As a member of the Senate Banking, Housing, and Urban Affairs Committee, and specifically its Subcommittee on Economic Policy and potentially Digital Assets 23, McCormick is directly involved in drafting the legislative framework that will govern the asset class he is accumulating.

3.1 The Legislative Catalyst: The BITCOIN Act and Market Structure

The primary context for these trades is the advancement of digital asset legislation in the Senate. During the same period McCormick was buying BITB, the Senate Agriculture Committee (led by Senator John Boozman) released a bipartisan discussion draft of the "Digital Commodities Consumer Protection Act" (or similar market structure bill) on November 10, 2025.26

This draft legislation aims to grant the Commodity Futures Trading Commission (CFTC) exclusive jurisdiction over "digital commodities," specifically Bitcoin and Ether, classifying them as commodities rather than securities.27 This classification is the "holy grail" for the crypto industry, as the CFTC is viewed as a more favorable and pragmatic regulator than the Securities and Exchange Commission (SEC).

Furthermore, Senator Cynthia Lummis introduced the "BITCOIN Act of 2025" (S. 954), proposing the establishment of a Strategic Bitcoin Reserve for the United States.29 This bill, referred to the Senate Banking Committee (McCormick’s committee), would mandate the U.S. government to hold Bitcoin as a strategic reserve asset, similar to gold.

3.2 Analyzing the Conflict and the Signal

The confluence of these factors creates a potent signal for investors:

1. Legislative Momentum: The release of the Senate Ag draft and the introduction of the BITCOIN Act indicate a coordinated push to formalize Bitcoin’s status in the U.S. financial system by early 2026.
2. Committee Insight: McCormick’s aggressive buying suggests he possesses high confidence that these legislative efforts will either pass or gain enough traction to drive market sentiment. His position on the Banking Committee gives him a front-row seat to the negotiations between the Banking and Ag committees regarding jurisdiction.28
3. ETF Selection: The choice of the Bitwise ETF (BITB) specifically, rather than direct Bitcoin or other ETFs, is also noteworthy. Bitwise is known for its transparency (publishing wallet addresses) and low fees, and has committed 10% of profits to open-source development.31 This aligns with a "policy-friendly" investment approach that supports the ecosystem's infrastructure.

For the user, the insight is clear: Regulatory clarity is imminent. The accumulation of Bitcoin exposure by a key Banking Committee member signals that the "regulatory risk" discount currently applied to crypto assets may evaporate in early 2026. This makes Bitcoin and its proxies (like IREN, discussed above) strong candidates for "sleeper" status before the legislation advances further.

---

4. Healthcare Policy Arbitrage: The BioCryst and Guardant Health Anomalies

While the tech and crypto trades dominate in volume, the healthcare transactions in the dataset offer perhaps the clearest examples of "event-driven" trading correlated with regulatory milestones. These trades often precede FDA decisions or reimbursement updates, allowing members to capitalize on binary events.

4.1 BioCryst Pharmaceuticals (BCRX): The Pediatric Approval Play

Representative Gilbert Cisneros (D-CA) purchased BioCryst Pharmaceuticals (NASDAQ: BCRX) on November 13, 2025.1 At the time of the purchase, BioCryst was awaiting an FDA decision on a pediatric formulation of its flagship drug, ORLADEYO.

The Catalyst: FDA Approval

On December 12, 2025—roughly one month after Cisneros's purchase—BioCryst announced that the FDA had approved ORLADEYO oral pellets for children aged 2 to 11 with hereditary angioedema (HAE).32 This approval made ORLADEYO the first and only oral prophylactic therapy for this age group, significantly expanding the drug's total addressable market.

The Financial Impact

Prior to this approval, BioCryst had already raised its full-year 2025 revenue guidance for ORLADEYO to between $590 million and $600 million.35 The pediatric indication opens access to a demographic that historically relied on burdensome injectable treatments. Additionally, the company announced the early termination of the HSR waiting period for its acquisition of Astria Therapeutics, creating a consolidated HAE powerhouse.36 The stock reacted positively to the news, and the "sleeper" window for this specific catalyst has likely closed. However, the insight here validates the strategy of watching congressional trades for "PDUFA run-up" plays (purchasing before Prescription Drug User Fee Act dates).

4.2 Guardant Health (GH): The Screening Legislation Play

Senator Sheldon Whitehouse (D-RI) executed two purchases of Guardant Health (NASDAQ: GH) on November 21, 2025.1 Guardant Health is a leader in precision oncology, specifically liquid biopsy tests for cancer screening.

The Legislative Catalyst: Cancer Screening Coverage

Senator Whitehouse serves on the Senate Finance Committee, which has jurisdiction over Medicare and Medicaid reimbursement policies.37 In late 2025, there was significant legislative activity regarding cancer screening coverage:

• Federal Reimbursement: Crucially, Guardant Health announced in early 2025 that its "Shield" colorectal cancer blood test received "Advanced Diagnostic Laboratory Test" (ADLT) status from CMS, locking in a reimbursement rate of $1,495 for Medicare patients starting April 2025.39
• Legislative Momentum: On November 24, 2025 (three days after Whitehouse’s trade), the Governor of Pennsylvania signed SB 88, expanding insurance coverage for breast cancer screenings.40 While a state law, it reflects a broader national push supported by federal representatives like Rep. Kathy Castor and Rep. Brian Fitzpatrick who reintroduced the "Increasing Access to Lung Cancer Screening Act".41
• Commercial Expansion: Guardant is aggressively expanding its sales force to 600-700 reps to capitalize on these new reimbursement rates in 2026.42

The Sleeper Thesis

The accumulation by Senator Whitehouse suggests confidence in the continued expansion of reimbursement for liquid biopsies. The transition of the "Shield" test from a novel diagnostic to a standard-of-care screening tool reimbursed by Medicare represents a massive revenue inflection point for 2026. Given the Senator's role in healthcare finance oversight, his purchase signals a belief that federal reimbursement headwinds are clearing. Guardant Health remains a compelling "sleeper" for 2026 as these reimbursement rates fully impact earnings.

4.3 Organon (OGN): The Informed Exit

Senator Gary Peters (D-MI) sold Organon (NYSE: OGN) in October 2025.1 This sale proved prescient, as Organon later lowered its full-year 2025 revenue guidance to $6.20-$6.25 billion due to foreign exchange headwinds and generic competition.43 Additionally, the company faced internal investigations regarding the sales practices of its Nexplanon product, which shook investor confidence.44 Senator Peters' sale prior to the full realization of these headwinds demonstrates the value of monitoring congressional sales as indicators of deteriorating fundamentals or regulatory risk.

---

5. The Macro-Housing Pivot: John Boozman’s Portfolio Rotation

A highly unusual and specific pattern of trading was observed in the portfolio of Senator John Boozman (R-AR), the Ranking Member (and incoming Chairman) of the Senate Agriculture, Nutrition, and Forestry Committee.45 On November 21, 2025, Senator Boozman executed a massive portfolio rotation, selling broad equity ETFs and buying fixed-income securities focused on the mortgage market.

5.1 The Trades: Selling Equities, Buying Mortgages

Senator Boozman sold shares in broad market indices and commodities:

• Sold: iShares Core S\&P 500 (IVV), iShares Russell 2000 (IWM), First Trust Global Tactical Commodity (FTGC), Vanguard Real Estate (VNQI).

He reallocated this capital into Mortgage-Backed Securities (MBS) and intermediate fixed income:

• Bought: iShares MBS ETF (MBB), Janus Henderson Mortgage-Backed Securities ETF (JMBS), iShares CMBS ETF (CMBS).

5.2 The Legislative Context: Rural Housing and Interest Rates

This rotation is not merely a defensive move; it is a policy-driven bet. As Chairman of the Senate Ag Committee, Boozman has jurisdiction over the USDA’s Rural Housing Service (RHS), which plays a critical role in rural mortgage lending.46

In November 2025, Boozman chaired hearings on rural development, emphasizing the need for affordable housing and access to credit in rural America.46 The committee is also heavily involved in the "ROAD to Housing Act of 2025" (S. 2651), which aims to reform rural housing programs and increase supply.48

5.3 The Macro Thesis: Peak Rates

By buying MBS ETFs (MBB, JMBS), Boozman is effectively going "long" on the U.S. housing market's liquidity and betting that interest rates have peaked. Mortgage-backed securities increase in value as interest rates fall.

• Fed Action: In late 2025, the Federal Reserve cut interest rates by 0.25%, signaling a dovish pivot.49
• Mortgage Rates: Mortgage rates began to decline in November/December 2025, dropping to around 6.18%.51

Insight: The incoming Chairman of the committee responsible for rural housing is betting heavily that the mortgage market will stabilize and that rates will fall in 2026. This is a strong macro signal for the housing sector and related financial assets. It suggests that legislative support for housing liquidity will be a priority in the 119th Congress.

---

6. Financial Consolidation & Consumer Discretionary: The Merger and Turnaround Plays

6.1 Capital One (COF): The Merger Arbitrage

Senator Markwayne Mullin (R-OK) purchased between $50,000 and $100,000 of Capital One Financial (NYSE: COF) on November 10, 2025.1 This trade occurred amidst the regulatory endgame of Capital One's acquisition of Discover Financial Services (NYSE: DFS).

The acquisition, valued at over $35 billion, creates the largest credit card issuer in the United States by loan volume.52 By November 2025, the deal had cleared significant hurdles, including approval from the Office of the Comptroller of the Currency (OCC) and the Federal Reserve, despite opposition from some Democrats.52

Senator Mullin’s purchase—after the riskiest regulatory hurdles were cleared but before the full integration synergies were realized—suggests a "merger arbitrage" play. The combined entity is projected to generate $1.2 billion in network synergies by 2027.54 Mullin’s purchase indicates a belief that the deal will close successfully (expected early 2026) and that the long-term value of the combined payment network is underestimated.

6.2 Cracker Barrel (CBRL): The Volatility Play

Representative Tim Moore (R-NC) engaged in active, high-frequency trading of Cracker Barrel Old Country Store (NASDAQ: CBRL) throughout December 2025.1

• Dec 9: Bought $50k-$100k.
• Dec 10: Sold $50k-$100k.
• Dec 16: Bought $15k-$50k.

This activity coincided with Cracker Barrel's Q1 2026 earnings release on December 9, 2025. The company reported a net loss and missed revenue estimates, causing the stock to hit a 52-week low.55

Moore's trading pattern—buying on the dip, selling on a bounce/stop-loss, and re-entering—suggests a conviction that the stock is oversold or a "dead cat bounce" strategy. Unlike the structural tailwinds powering IREN or Guardant, this appears to be a valuation play based on the belief that the brand's equity is undervalued by the market, potentially anticipating a turnaround or private equity interest similar to other restaurant chains.

6.3 Alkami Technology (ALKT): The Activist Target

Representative Gilbert Cisneros (D-CA) purchased Alkami Technology (NASDAQ: ALKT) on November 13, 2025.1 This trade aligns perfectly with reports of activist investor Jana Partners building a stake in the company and urging a sale.57

Jana Partners argues that Alkami is undervalued and should explore a sale to a rival or private equity firm. The stock jumped on the news. Cisneros’s purchase suggests he may have been aware of the building "activist pressure" narrative or simply identified the same value dislocation. With Alkami hosting its "Co:lab 2026" conference in April to showcase new digital banking products 59, the stock has multiple catalysts: potential M\&A activity or organic growth demonstration.

---

7. Portfolio Reconstruction: The Gilbert Cisneros "Whale" Trade

Representative Gilbert Cisneros (D-CA) exhibited the most significant "unusual activity" in terms of volume and portfolio rotation. In November 2025, Cisneros executed dozens of trades, effectively reconstructing his entire portfolio.1

• Selling: Broad tech exposure (GOOGL), legacy media (CMCSA), and industrials (ITT, KMB).
• Buying: A diversified basket of "real economy" stocks including First Watch Restaurant Group (FWRG), Alkami Technology (ALKT), BioCryst (BCRX), and heavy industrials/energy like GE Vernova (GEV), Coterra Energy (CTRA), and Chevron (CVX).

Analysis: Cisneros is rotating out of the "Magnificent Seven" trade (selling Google) and into:

1. Domestic Consumption: First Watch (FWRG) is expanding aggressively (aiming for 2,200 units) and buying back franchises.60
2. Energy Realism: Buying traditional energy (Chevron, Coterra) and grid infrastructure (GE Vernova). This aligns with the "AI requires energy" thesis but focuses on the suppliers of that energy.
3. Small-Cap Growth: Taking positions in Alkami and BioCryst suggests a risk-on appetite for specific, catalyst-driven small caps rather than passive index exposure.

---

8. Strategic Recommendations: The "Sleeper" Watchlist

Based on the synthesis of congressional trading data, legislative activity, and corporate fundamentals, the following assets are identified as high-conviction "sleeper" opportunities for the first quarter of 2026.

1. IREN Limited (NASDAQ: IREN)

• The Thesis: IREN is mispriced as a Bitcoin miner when it is effectively becoming a critical AI infrastructure utility. The $9.7 billion Microsoft contract provides a floor for valuation.
• Congressional Signal: Accumulation by Rep. Cleo Fields (Financial Services).
• Catalyst: Acceleration of FERC interconnection rules in 2026 making its 3GW of secured power increasingly valuable. Target revenue of $3.4B ARR by end of 2026.5

2. Guardant Health (NASDAQ: GH)

• The Thesis: The company is at a pivotal inflection point where clinical utility (FDA approvals) meets commercial viability (Medicare reimbursement).
• Congressional Signal: Accumulation by Senator Sheldon Whitehouse (Finance Committee) immediately preceding state/federal screening coverage pushes.
• Catalyst: Implementation of ADLT pricing ($1,495) in April 2025/2026 and potential FDA approval of Guardant360 Liquid.

3. First Watch Restaurant Group (NASDAQ: FWRG)

• The Thesis: Profitable expansion in a contracting industry. Dominant in "daytime dining" niche with favorable labor economics.
• Congressional Signal: Purchase by Rep. Gilbert Cisneros.
• Catalyst: Continued unit growth (59-64 new units) and franchise acquisitions boosting margins.

4. Bitwise Bitcoin ETF (BITB)

• The Thesis: Structural shift in U.S. regulatory stance. Senate Ag push for CFTC jurisdiction removes existential regulatory risk.
• Congressional Signal: Aggressive buying by Senator Dave McCormick (Banking Committee).
• Catalyst: Potential passage of the BITCOIN Act (Strategic Reserve) or market structure bills in 2026.

5. Alkami Technology (ALKT)

• The Thesis: High-quality fintech asset currently under activist pressure to sell.
• Congressional Signal: Purchase by Rep. Gilbert Cisneros during activist accumulation.
• Catalyst: Potential M\&A announcement or strategic review driven by Jana Partners.

9. Conclusion

The data indicates that members of Congress are positioning themselves for a specific version of the future: one where AI consumes vast amounts of energy, cryptocurrency becomes a regulated commodity, and specialized healthcare diagnostics receive government-backed reimbursement.

The trades analyzed—specifically the rotation into AI power infrastructure (IREN), the accumulation of crypto assets by banking committee members (BITB), and the pivot to mortgage-backed securities by agricultural leaders (MBB)—are not merely financial transactions. They are bets on the success of the very policies these members are crafting. The window to act on this information arbitrage is likely narrowing as the market begins to price in the regulatory clarity emerging in 2026.

Works cited

1. Congress-stock-transactions - Sheet1.csv
2. US Congress Representative Cleo Fields [D] - LegiScan, accessed December 30, 2025, https://legiscan.com/US/people/cleo-fields/id/25863
3. Committees and Caucuses | Representative Cleo Fields - House.gov, accessed December 30, 2025, https://fields.house.gov/about/committees-and-caucuses
4. Prediction: 1 Artificial Intelligence Stock Will Lead the Next Bull Market, accessed December 30, 2025, https://www.fool.com/investing/2025/12/28/prediction-1-artificial-intelligence-stock-will-le/
5. IREN (IREN) Q1 2026 Earnings - MLQ.ai | AI for investors, accessed December 30, 2025, https://mlq.ai/stocks/IREN/q1-2026-earnings/
6. Iris Energy Limited Stock (IREN) Opinions on Recent Price Volatility and AI Strategy, accessed December 30, 2025, https://www.quiverquant.com/news/Iris+Energy+Limited+Stock+%28IREN%29+Opinions+on+Recent+Price+Volatility+and+AI+Strategy
7. HEARINGS NOTICE: House Financial Services Committee Schedule for December 2025, accessed December 30, 2025, https://financialservices.house.gov/news/documentsingle.aspx?DocumentID=410911
8. Financial Services Committee Examines Artificial Intelligence in Financial Services | U.S. House Committee on Financial Services, accessed December 30, 2025, https://financialservices.house.gov/news/documentsingle.aspx?DocumentID=410946
9. Markets News, Dec. 29, 2025: Major Stock Indexes Close Lower to Start Holiday-Shortened Week; Gold, Silver Retreat From Record Highs, accessed December 30, 2025, https://www.investopedia.com/dow-jones-today-12292025-11876790
10. Lee, Heinrich, Back DOE Proposal Requiring FERC Action on Large-Load Grid Connections, accessed December 30, 2025, https://www.energy.senate.gov/2025/11/lee-heinrich-back-doe-proposal-requiring-ferc-action-on-large-load-grid-connections
11. Environmental groups to Congress: Take a timeout on AI data centers | FedScoop, accessed December 30, 2025, https://fedscoop.com/pause-ai-data-centers-letter-to-congress/
12. Can Iren Stock Beat the Market in 2026? | The Motley Fool, accessed December 30, 2025, https://www.fool.com/investing/2025/12/21/can-iren-stock-beat-the-market/
13. CoreWeave shares moving lower ahead of its post-IPO lock-up expiration - YouTube, accessed December 30, 2025, https://www.youtube.com/watch?v=JyrxhTy4J9c
14. CoreWeave Stock Soars: Time to Buy? | The Motley Fool, accessed December 30, 2025, https://www.fool.com/investing/2025/12/20/coreweave-stock-soars-time-to-buy/
15. Coreweave, Inc IPOs Tomorrow, Here's What You Need To Know - Sahm, accessed December 30, 2025, https://www.sahmcapital.com/news/content/coreweave-inc-ipos-tomorrow-heres-what-you-need-to-know-2025-03-27
16. Lockup and float - Fintel, accessed December 30, 2025, https://fintel.io/topic/lockup-and-float-1337-4072
17. CoreWeave Reports Strong Third Quarter 2025 Results, accessed December 30, 2025, https://investors.coreweave.com/news/news-details/2025/CoreWeave-Reports-Strong-Third-Quarter-2025-Results/
18. The "Second Derivative" AI Stocks: 3 Companies That Could Thrive Beyond Chips in 2026, accessed December 30, 2025, https://www.fool.com/investing/2025/12/29/the-second-derivative-ai-stocks-3-companies-that-c/
19. SoundHound AI Executives Sell Shares to Meet Tax Obligations - TradingView, accessed December 30, 2025, https://www.tradingview.com/news/tradingview:479eafa5d2945:0-soundhound-ai-executives-sell-shares-to-meet-tax-obligations/
20. SoundHound AI (NASDAQ:SOUN) Stock Price Down 2.7% - Here's What Happened, accessed December 30, 2025, https://www.marketbeat.com/instant-alerts/soundhound-ai-nasdaqsoun-stock-price-down-27-heres-what-happened-2025-12-29/
21. Texas Instruments' $40 billion semiconductor factory brings thousands of jobs to North Texas - CBS News, accessed December 30, 2025, https://www.cbsnews.com/texas/news/texas-instruments-40-billion-semiconductor-factory-thousands-of-jobs-north-texas/
22. Texas Instruments (TXN) Fell Due to Below-Expected Guidance - Finviz, accessed December 30, 2025, https://finviz.com/news/225778/texas-instruments-txn-fell-due-to-below-expected-guidance
23. Pennsylvania's senators assigned to committees | News, Sports, Jobs, accessed December 30, 2025, https://www.sungazette.com/news/top-news/2025/01/pennsylvanias-senators-assigned-to-committees/
24. Committee Assignments - U.S. Senator Dave McCormick, accessed December 30, 2025, https://www.mccormick.senate.gov/about/committee-assignments/
25. Senator Dave McCormick reveals up to $150K purchase of Bitwise Bitcoin ETF this week, accessed December 30, 2025, https://www.tradingview.com/news/cryptobriefing:fbc0f4152094b:0-senator-dave-mccormick-reveals-up-to-150k-purchase-of-bitwise-bitcoin-etf-this-week/
26. Senate Releases Bipartisan Draft To Regulate Digital Commodity Markets, accessed December 30, 2025, https://mwcllc.com/2025/11/12/bipartisan-senate-crypto-bill/
27. Recent Updates on Market Structure Legislation: Senate Agriculture Committee Releases Draft | Paul Hastings LLP, accessed December 30, 2025, https://www.paulhastings.com/insights/crypto-policy-tracker/recent-updates-on-market-structure-legislation-senate-agriculture-committee-releases-draft
28. Crypto's next chapter: What the Senate Agriculture Committee draft means for digital commodities - Reed Smith LLP, accessed December 30, 2025, https://www.reedsmith.com/articles/crypto-s-next-chapter-what-the-senate-agriculture-committee-draft-means-for-digital-commodities/
29. S.954 - BITCOIN Act of 2025 119th Congress (2025-2026), accessed December 30, 2025, https://www.congress.gov/bill/119th-congress/senate-bill/954
30. Text - S.954 - 119th Congress (2025-2026): BITCOIN Act of 2025, accessed December 30, 2025, https://www.congress.gov/bill/119th-congress/senate-bill/954/text
31. The Bitwise Bitcoin ETF (BITB) Begins Trading With 0.20% Management Fee, accessed December 30, 2025, https://bitwiseinvestments.com/newsroom/the-bitwise-bitcoin-etf-bitb-begins-trading
32. Press Releases | BioCryst Pharmaceuticals, Inc., accessed December 30, 2025, https://ir.biocryst.com/news-events/press-releases
33. BCRX BIOCRYST PHARMACEUTICALS INC Product Launches 8-K Filing - stockinsights.ai, accessed December 30, 2025, https://www.stockinsights.ai/us/BCRX/8-K/product-launches-20251212-5af
34. BioCryst Announces FDA Approval of ORLADEYO® (berotralstat) Oral Pellets, First and Only Oral Prophylactic Treatment for Patients with HAE Aged 2 to \<12 Years - GlobeNewswire, accessed December 30, 2025, https://www.globenewswire.com/news-release/2025/12/12/3204568/29446/en/BioCryst-Announces-FDA-Approval-of-ORLADEYO-berotralstat-Oral-Pellets-First-and-Only-Oral-Prophylactic-Treatment-for-Patients-with-HAE-Aged-2-to-12-Years.html
35. BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update, accessed December 30, 2025, https://www.globenewswire.com/news-release/2025/11/03/3179064/0/en/BioCryst-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html
36. BioCryst Pharmaceuticals Announces Early Termination of HSR Waiting Period for Astria Therapeutics Acquisition - Quiver Quantitative, accessed December 30, 2025, https://www.quiverquant.com/news/BioCryst+Pharmaceuticals+Announces+Early+Termination+of+HSR+Waiting+Period+for+Astria+Therapeutics+Acquisition
37. About - Senator Sheldon Whitehouse, accessed December 30, 2025, https://www.whitehouse.senate.gov/about/
38. Membership | About | The United States Senate Committee on Finance, accessed December 30, 2025, https://www.finance.senate.gov/about/membership
39. Guardant Health Receives ADLT Status From CMS for Shield Blood Test, accessed December 30, 2025, https://investors.guardanthealth.com/press-releases/press-releases/2025/Guardant-Health-Receives-ADLT-Status-From-CMS-for-Shield-Blood-Test/default.aspx
40. Pennsylvania Bill to Expand Breast Cancer Screening Coverage - NFP, accessed December 30, 2025, https://www.nfp.com/insights/pennsylvania-bill-to-expand-breast-cancer-screening-coverage/
41. Castor, Fitzpatrick, Wasserman Schultz, Lawler Introduce Bipartisan Legislation to Increase Access to Lung Cancer Screenings, accessed December 30, 2025, https://castor.house.gov/news/documentsingle.aspx?DocumentID=405078
42. Guardant Health at Jefferies: Promising Growth in Cancer Screening - Investing.com, accessed December 30, 2025, https://www.investing.com/news/transcripts/guardant-health-at-jefferies-promising-growth-in-cancer-screening-93CH-4367166
43. Organon Reports Results for the Third Quarter Ended September 30, 2025, accessed December 30, 2025, https://www.organon.com/news/organon-reports-results-for-the-third-quarter-ended-september-30-2025/
44. Organon (OGN) Stock Trades Down, Here Is Why - StockStory, accessed December 30, 2025, https://stockstory.org/us/stocks/nyse/ogn/news/why-up-down/organon-ogn-stock-trades-down-here-is-why
45. Boozman Announces Committee Assignments for 119th Congress, Assumes Chairmanship of Ag Committee - Press Releases, accessed December 30, 2025, https://www.boozman.senate.gov/public/index.cfm/2025/1/boozman-announces-committee-assignments-for-119th-congress-assumes-chairmanship-of-ag-committee
46. Chairman Boozman Highlights Importance of Rural Development at Nomination Hearing, accessed December 30, 2025, https://www.agriculture.senate.gov/newsroom/rep/press/release/chairman-boozman-highlights-importance-of-rural-development-at-nomination-hearing
47. United States Senate Committee on Agriculture, Nutrition, and Forestry - Wikipedia, accessed December 30, 2025, https://en.wikipedia.org/wiki/United_States_Senate_Committee_on_Agriculture,_Nutrition,_and_Forestry
48. ROAD to Housing Act of 2025 - Congress.gov, accessed December 30, 2025, https://www.congress.gov/crs-product/R48732
49. Fed Rate Cut November 2025: What It Means - TEG Federal Credit Union, accessed December 30, 2025, https://www.tegfcu.com/mortgage/fed-rate-cut-november-2025/
50. Federal Reserve issues FOMC statement, accessed December 30, 2025, https://www.federalreserve.gov/newsevents/pressreleases/monetary20251210a.htm
51. Mortgage Rates - Freddie Mac, accessed December 30, 2025, https://www.freddiemac.com/pmms
52. US regulators approve Capital One–Discover merger deal - The Paypers, accessed December 30, 2025, https://thepaypers.com/payments/news/capital-onediscover-merger-gets-final-green-light-from-us-regulators
53. Ranking Member Waters Testifies Against Proposed Capital One-Discover Merger at Regulators' Public Meeting | U.S. House Committee on Financial Services Democrats, accessed December 30, 2025, https://democrats-financialservices.house.gov/news/documentsingle.aspx?DocumentID=412626
54. Capital One to Acquire Discover | Capital One Financial Corp. - Investor Relations, accessed December 30, 2025, https://investor.capitalone.com/news-releases/news-release-details/capital-one-acquire-discover/
55. CRACKER BARREL REPORTS FIRST QUARTER FISCAL 2026 RESULTS AND UPDATES FISCAL 2026 OUTLOOK | Cracker Barrel Old Country Store, Inc. - Investors, accessed December 30, 2025, https://investor.crackerbarrel.com/news-releases/news-release-details/cracker-barrel-reports-first-quarter-fiscal-2026-results-and
56. Cracker Barrel Old Country Store (NASDAQ:CBRL) Sets New 12-Month Low After Insider Selling - MarketBeat, accessed December 30, 2025, https://www.marketbeat.com/instant-alerts/cracker-barrel-old-country-store-nasdaqcbrl-sets-new-12-month-low-after-insider-selling-2025-12-29/
57. Activist investor Jana Partners urges Alkami to explore sale - Investing.com, accessed December 30, 2025, https://www.investing.com/news/stock-market-news/activist-investor-jana-partners-urges-alkami-to-explore-sale-93CH-4399605
58. By Svea Herbst-Bayliss New York, Nov 14 (Re - moomoo, accessed December 30, 2025, https://news.moomoo.com/flash/21433688/exclusive-jana-partners-built-new-stake-in-alkami-technology-in
59. Alkami (ALKT) unveils 6 breakout tracks for Co:lab 2026 - Stock Titan, accessed December 30, 2025, https://www.stocktitan.net/news/ALKT/alkami-announces-breakout-tracks-for-alkami-co-lab-2026-highlighting-90hcoj5scn61.html
60. How First Watch's expansion is outpacing casual dining growth - Restaurant Dive, accessed December 30, 2025, https://www.restaurantdive.com/news/first-watch-annual-unit-growth-outpaces-casual-dining/802124/
61. First Watch to Acquire 16 Franchise Restaurants in North and South Carolina, accessed December 30, 2025, https://investors.firstwatch.com/news-releases/news-release-details/first-watch-acquire-16-franchise-restaurants-north-and-south/